[Sustained reduction of fracture risk in high compliance].

[Sustained reduction of fracture risk in high compliance]. [electronic resource] - MMW Fortschritte der Medizin Jul 2015 - 86-7 p. digital

Publication Type: News; Randomized Controlled Trial

1438-3276

10.1007/s15006-015-3325-6 doi


Aged
Aged, 80 and over
Bone Density--drug effects
Bone Density Conservation Agents--therapeutic use
Denosumab--therapeutic use
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Osteoporotic Fractures--prevention & control
Patient Compliance
Risk Factors